Skip to content

Changes of gut microbiota and metabolites in functional constipation in Chinese children of young age

Changes of gut microbiota and metabolites in functional constipation in Chinese children of young age

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024850
Enrollment
Unknown
Registered
2019-07-31
Start date
2019-03-14
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional constipation in children

Interventions

Functional constipation:Nil
control:none

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 7 Years

Inclusion criteria

Inclusion criteria: Constipation group: Children who was admitted to the Pediatric Outpatient Clinic of Peking University Third Hospital, and diagnosed with functional constipation by the Pediatric Digestive Professional Group was based on the diagnostic criteria for Roman IV (G7 standard under 4 years old, H3a standard over 4 years old). Children diagnosed with functional constipation agree to sign an informed consent form and can cooperate with the retention of stool specimens. Healthy control group: Same age as the constipation group, the healthy and not constipated children who were reviewed at the Peking University Third Hospital Children's Health Care Center.

Exclusion criteria

Exclusion criteria: 1. Have "Warning symptoms" of suspected organic diseases: The first bowel movement occurred 48 hours after birth, constipation within 1 month after birth, family history of congenital megacolon, flat strips of feces, no anal fissure but fecal blood, Developmental stagnation, biliary vomiting, severe abdominal distension, thyroid abnormalities, abnormal anal position, loss of anal reflex or cremaster reflex, lower limb muscle strength/tension/reflex decline, shallow humeral depression, clustered hair on the spine, gluteal eccentricity, Anal scars; 2. The application history of antibiotics and probiotics preparations within 4 weeks before enrollment; 3. Disagree with follow-up and retention of specimens; 4. There are other long-term diseases; 5. Participate in other interventional trials.

Design outcomes

Primary

MeasureTime frame
fecal microbiota;fecal short-chain fatty acids;fecal bile acid;fecal bile acid;

Countries

China

Contacts

Public ContactZailing Li

Peking University Third Hospital

toplzl@126.com+86 13810095709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026